eMedicine Specialties > Plastic Surgery > Nose

Rhinoplasty, Turbinate Reduction

Author: Elizabeth Whitaker, MD, Clinical Assistant Professor, Department of Otolaryngology, Division of Facial Plastic Surgery, Atlanta Surgical Group, PC
Contributor Information and Disclosures

Updated: Dec 17, 2008

Introduction

History of the Procedure

Inferior turbinate surgery dates to the 1890s when Jones first described it. In 1900, Holmes described the stages of inferior turbinate hypertrophy and his surgical experience with 1500 turbinectomies. Turbinectomy later fell out of favor because of rising concern over complications such as rhinitis sicca, atrophic rhinitis, and ozena. The enlarged nasal cavity resulting from turbinate resection was believed to increase nasal airflow and reduce the humidifying capabilities of the nasal mucosa, resulting in drying, crusting, and mucosal atrophy. However, several studies have reported large series of turbinectomies without these complications. This aspect of turbinate surgery remains controversial.

Problem

Nasal obstruction after rhinoplasty can result from alteration of the nasal valve or nasal vault narrowing as a result of osteotomies. Beekhuis concluded that nasal obstruction postrhinoplasty resulted primarily from inferior turbinate hypertrophy.1 Changes in nasal airflow as a result of rhinoplasty may unmask inferior turbinate hypertrophy and obstruction that were not clinically significant or evident preoperatively.

Etiology

Mink described the nasal valve in 1903. The nasal valve is formed medially by the septum and laterally by the caudal edge of the upper lateral cartilage and it accounts for approximately 50% of total upper airway resistance. The anterior tip of the inferior turbinate is found in the nasal valve region, and hypertrophy of this structure can cause exponential increases in airway resistance.

Inferior turbinate hypertrophy can result from mucosal hypertrophy, bony hypertrophy, or both. Bony hypertrophy causes a fixed structural obstruction and is best treated with surgery. More commonly, the problem is mucosal hypertrophy causing impingement on the nasal valve, increased nasal resistance, and nasal obstruction. This can be managed medically or surgically depending on the degree of hypertrophy and responsiveness to medical management.

Pathophysiology

The nose is a complex and highly specialized organ that plays a role in olfaction, heat exchange, speech production, respiration, humidification, filtration, and antimicrobial defense.

Mucus production is provided by goblet cells and submucosal and seromucous glands. Mucus production is primarily controlled by parasympathetic innervation. The mucous blanket serves to humidify and clean the inspired air and eliminate debris from the nasal airway.

Nasal obstruction may be produced by overactivity of the parasympathetic innervation or underactivity of the sympathetic innervation. Resistance is important in nasal function and turbulence optimizes inspiratory air contact with the mucous membrane. Resistance must remain within certain limits for the perception of normal breathing. If it is too high or too low, a sensation of obstruction may occur. A cyclic alteration of constriction and dilation of the inferior turbinates, known as the nasal cycle, occurs approximately every 2-7 hours.

The nasal valve provides approximately 50% of total airway resistance. The nasal valve is the region of the nasal airway extending from the caudal end of the upper lateral cartilages and including the anterior end of the inferior turbinate. As airflow enters this constricted segment, it accelerates and the pressure drops (per Bernoulli principle), which can result in nasal valve collapse if the upper lateral cartilages are anatomically weak. The erectile tissue of the nasal septum and inferior turbinate can impinge on the nasal valve and increase resistance. Because the cross-sectional area of the nasal valve is small, minor changes in inferior turbinate congestion can have marked effects on resistance. A major determinant of resistance to airflow is the radius of the nasal vault. However, even in the presence of a normal radius, a sensation of obstruction can occur from turbulent airflow.

Presentation

History

Nasal obstruction is a common complaint. Discerning the etiology is important so that appropriate treatment can be initiated. History should address any alteration or unilaterality of the obstruction, which may indicate a dynamic versus structural problem.

Address symptoms of rhinitis. Obstruction, rhinorrhea, and sneezing may occur with allergic and nonallergic rhinitis. Elicit systemic symptoms of allergy such as watery itchy eyes, asthma, and seasonal variation. Initial general examination should note "allergic shiners" or a facial appearance that may indicate signs of chronic nasal obstruction. Vasomotor rhinitis is typically exacerbated by irritants, temperature or humidity changes, or psychological factors. Nonallergic eosinophilic rhinitis is generally perennial without allergen-induced symptoms. Atrophic rhinitis is characterized by nasal dryness and crusting, frequently with a foul odor. Rhinitis can also be associated with pregnancy and with systemic disorders such as hypothyroidism.

Medications can also cause rhinitis and nasal obstruction. Rhinitis medicamentosa results from rebound vasodilation after prolonged use of topical nasal decongestants. Typically the patient begins using the topical agent to treat an underlying disorder causing the nasal obstruction. Other medications causing increased nasal congestion include certain antihypertensives, antidepressants, antipsychotics, and oral contraceptives.

Examination

Physical examination of the external nose is, of course, critical. In addition to assessing nasal aesthetics, note the patency of the nasal valve and any alar collapse since these may need to be addressed to ensure functionality of the nose postrhinoplasty. The Cottle maneuver involves pulling the patient's cheek laterally to open the nasal valve angle. If nasal airflow symptomatically improves, this may indicate nasal valve pathology. A crooked nose may indicate prior trauma and this history should be elicited. A saddle nose deformity may indicate previous trauma, prior surgery, cocaine abuse, or an inflammatory process.

Additionally, the focus of the physical examination is anterior rhinoscopy, which reveals caudal septal deformities or inferior turbinate hypertrophy that may account for the patient's symptoms. If the patient has a significant caudal septal deflection, typically the inferior turbinate on the side opposite the deviation is enlarged. Apply topical decongestant to evaluate the response of the turbinate mucosa. This may assist in delineating mucosal versus bony hypertrophy.

If indicated based on history, symptoms, or signs, a more extensive examination of the nose can be performed via a rigid or flexible endoscope. This examination allows additional assessment of the septum posteriorly, the nasopharynx, and the sinus ostia. Nasal masses or polyps as a cause of obstruction can be evaluated. Purulent drainage may indicate sinusitis. Evidence of a septal perforation may indicate prior surgery, cocaine or topical decongestant abuse, or an inflammatory disease. Significant crusting or abnormality of the mucosal appearance may indicate a systemic disorder.

History or symptoms and signs of other systemic disorders that may affect the nose and turbinates warrant further investigation. Wegener granulomatosis and sarcoid can result in nasal obstruction and crusting. Infectious rhinitis can result from a variety of organism-caused conditions such as rhinoscleroma, tuberculosis, syphilis, rhinosporidiosis, histoplasmosis, and aspergillosis. If suspected, address a history of exposure and travel and perform further appropriate testing. A significant history of epistaxis may raise the concern of an inflammatory or neoplastic process.

Indications

Nasal obstruction may result from mucosal hypertrophy of the inferior turbinate, structural deformity of the nasal airway (septal deviation, bony inferior turbinate hypertrophy), or dynamic airway collapse.

Typically, in the patient with significant nasal septal deviation, unilateral compensatory turbinate hypertrophy may be present on the side opposite the deviation. However, if the septal deviation is S shaped or deflections exist bilaterally, then bilateral inferior turbinate enlargement may be present. If the hypertrophied turbinate is not addressed, nasal airway obstruction may persist despite correction of septal deformities.

Similarly, relative inferior turbinate hypertrophy occurs in patients with a narrow nasal vault either inherently or secondary to rhinoplasty maneuvers. Failure to perform reduction of the inferior turbinates may result in nasal airway obstruction despite correction of any septal deformities.

Relevant Anatomy

Lateral nasal wall

The lateral nasal wall is composed of the nasal, frontal, occipital, lacrimal, ethmoid, maxillary, and palatine bones. The inferior turbinate constitutes a separate bone and articulates with the maxilla, lacrimal, ethmoid, and palatine bones. The superior and middle turbinates project off the ethmoid bone. The lacrimal process of the inferior turbinate forms the medial wall of the nasolacrimal duct, which drains into the inferior meatus.

Nasal valve

The nasal valve is formed laterally by the caudal end of the upper lateral cartilages and medially by the septum. The anterior tip of the inferior turbinate lies in the area of the nasal valve.

Nasal mucosa

The nasal vestibule, constituting the first 1-2 cm of the nasal cavity, is lined with keratinized, stratified squamous epithelium containing hair follicles and sebaceous and sweat glands. At the mucocutaneous junction (limen nasi), the epithelium transitions to pseudostratified ciliated columnar cells. This epithelium lines most of the sinonasal tract with the exception of the olfactory mucosa.

Blood supply

The arterial blood supply to the nose originates from the maxillary and facial branches of the external carotid artery and from the ophthalmic branch of the internal carotid artery. The anterior facial vein, sphenopalatine vein, and ethmoid vein supply venous drainage. The nasal vasculature is composed of arterioles, submucosal capillary beds, and venules. Specifically, the nasal vasculature of the inferior turbinate is a sinusoidal network of large capacitance vessels. These sinusoidal vessels are found primarily in the inferior turbinate and the anterior septum. The result is that the inferior turbinate functions as erectile tissue.

Constriction of postsinusoidal venules results in engorgement of the sinusoids and an enlargement of the nasal turbinates. In addition, multiple direct arteriovenous anastomoses bypass the capillary beds. This allows significant increases in blood flow and heat exchange without a great increase in nasal blood volume, which facilitates the temperature regulatory function of the inferior turbinates. The nasal mucosal vasculature is intimately related to its autonomic innervation.

Innervation

In general, the nose is innervated by the olfactory nerve, branches of the ophthalmic and maxillary divisions of the trigeminal nerve, parasympathetic secretomotor fibers, and sympathetic fibers. The autonomic nerve supply to the nose regulates vascular tone, turbinate congestion, and nasal secretion. Parasympathetic fibers synapse in the sphenopalatine ganglion before innervating nasal mucosa. These fibers travel with the facial nerve, exiting at the geniculate ganglion as the greater superficial petrosal nerve. The vidian nerve is formed by the union of the greater superficial petrosal and deep petrosal nerves and carries the fibers to the sphenopalatine ganglion, where they synapse.

Sympathetic fibers also pass through the sphenopalatine ganglion but do not synapse there. The sympathetic fibers exit the spine and travel in the cervical sympathetic trunk, synapsing in the superior cervical ganglion. Postsynaptic fibers contribute to the sympathetic plexus of the internal carotid artery from which the deep petrosal nerve originates. It then joins with the greater superficial petrosal nerve to form the vidian nerve and its fibers pass through the sphenopalatine ganglion and along branches of the trigeminal nerve and nasal blood vessels. Thus, branches of the sphenopalatine ganglion carry sympathetic, parasympathetic, and trigeminal fibers.

Contraindications

The inferior turbinates are very vascular structures and one of the risks of surgery is hemorrhage. Patients with coagulopathies are clearly at increased risk of complications. Similarly, patients should not be taking any medications or herbs that affect their coagulation cascade.

Take care when resecting turbinate tissue in patients who have preexisting reports of nasal dryness and crusting secondary to the concern about atrophic rhinitis.

More on Rhinoplasty, Turbinate Reduction

Overview: Rhinoplasty, Turbinate Reduction
Workup: Rhinoplasty, Turbinate Reduction
Treatment: Rhinoplasty, Turbinate Reduction
Follow-up: Rhinoplasty, Turbinate Reduction
Multimedia: Rhinoplasty, Turbinate Reduction
References

References

  1. Beekhuis GJ. Nasal obstruction after rhinoplasty: etiology, and techniques for correction. Laryngoscope. Apr 1976;86(4):540-8. [Medline].

  2. Cavaliere M, Mottola G, Iemma M. Comparison of the effectiveness and safety of radiofrequency turbinoplasty and traditional surgical technique in treatment of inferior turbinate hypertrophy. Otolaryngol Head Neck Surg. Dec 2005;133(6):972-8. [Medline].

  3. Fukazawa K, Ogasawara H, Tomofuji S, et al. Argon plasma surgery for the inferior turbinate of patients with perennial nasal allergy. Laryngoscope. Jan 2001;111(1):147-52. [Medline].

  4. Dawes PJ. The early complications of inferior turbinectomy. J Laryngol Otol. Nov 1987;101(11):1136-9. [Medline].

  5. Atef A, Mosleh M, El Bosraty H, et al. Bipolar radiofrequency volumetric tissue reduction of inferior turbinate: does the number of treatment sessions influence the final outcome?. Am J Rhinol. Jan-Feb 2006;20(1):25-31. [Medline].

  6. Bernstein L. Airway problems after rhinoplasty. Facial Plastic Surgery Clinics. November 1995;3(4):449-457.

  7. Berry RB. Nasal resistance before and after rhinoplasty. Br J Plast Surg. Jan 1981;34(1):105-11. [Medline].

  8. Bhattacharyya N, Kepnes LJ. Clinical effectiveness of coblation inferior turbinate reduction. Otolaryngol Head Neck Surg. Oct 2003;129(4):365-71. [Medline].

  9. Cavaliere M, Mottola G, Iemma M. Monopolar and bipolar radiofrequency thermal ablation of inferior turbinates: 20 month follow-up. Otolaryngol Head Neck Surg. Aug 2007;137(2):256-63. [Medline].

  10. Chang CW, Ries WR. Surgical treatment of the inferior turbinate: new techniques. Curr Opin Otolaryngol Head Neck Surg. Feb 2004;12(1):53-7. [Medline].

  11. Coste A, Yona L, Blumen M, et al. Radiofrequency is a safe and effective treatment of turbinate hypertrophy. Laryngoscope. May 2001;111(5):894-9. [Medline].

  12. Courtiss EH. Diagnosis and treatment of nasal airway obstruction due to inferior turbinate hypertrophy. Clin Plast Surg. Jan 1988;15(1):11-3. [Medline].

  13. Courtiss EH, Goldwyn RM. The effects of nasal surgery on airflow. Plast Reconstr Surg. Jul 1983;72(1):9-21. [Medline].

  14. Courtiss EH, Goldwyn RM, O'Brien JJ. Resection of obstructing inferior nasal turbinates. Plast Reconstr Surg. Aug 1978;62(2):249-57. [Medline].

  15. DeRowe A, Landsberg R, Leonov Y, et al. Subjective comparison of Nd:YAG, diode, and CO2 lasers for endoscopically guided inferior turbinate reduction surgery. Am J Rhinol. May-Jun 1998;12(3):209-12. [Medline].

  16. Elwany S, Harrison R. Inferior turbinectomy: comparison of four techniques. J Laryngol Otol. Mar 1990;104(3):206-9. [Medline].

  17. Farmer SE, Eccles R. Understanding submucosal electrosurgery for the treatment of nasal turbinate enlargement. J Laryngol Otol. Jul 2007;121(7):615-22. [Medline].

  18. Fischer Y, Gosepath J, Amedee RG, Mann WJ. Radiofrequency volumetric tissue reduction (RFVTR) of inferior turbinates: a new method in the treatment of chronic nasal obstruction. Am J Rhinol. Nov-Dec 2000;14(6):355-60. [Medline].

  19. Goldman IB. Rhinoplastic sequelae causing nasal obstruction. Arch Otolaryngol. Feb 1966;83(2):151-5. [Medline].

  20. Gordon AS, McCaffrey TV, Kern EB, Pallanch JF. Rhinomanometry for preoperative and postoperative assessment of nasal obstruction. Otolaryngol Head Neck Surg. Jul 1989;101(1):20-6. [Medline].

  21. Grymer LF, Illum P, Hilberg O. Septoplasty and compensatory inferior turbinate hypertrophy: a randomized study evaluated by acoustic rhinometry. J Laryngol Otol. May 1993;107(5):413-7. [Medline].

  22. Gupta A, Mercurio E, Bielamowicz S. Endoscopic inferior turbinate reduction: an outcomes analysis. Laryngoscope. Nov 2001;111(11 Pt 1):1957-9. [Medline].

  23. Harril WC, Pillsbury HC 3rd, McGuirt WF, Stewart MG. Radiofrequency turbinate reduction: a NOSE evaluation. Laryngoscope. Nov 2007;117(11):1912-9. [Medline].

  24. Hol MK, Huizing EH. Treatment of inferior turbinate pathology: a review and critical evaluation of the different techniques. Rhinology. Dec 2000;38(4):157-66. [Medline].

  25. Jessen M, Jacobsson S, Malm L. On rhinomanometry in rhinoplasty. Plast Reconstr Surg. Apr 1988;81(4):506-11. [Medline].

  26. Joniau S, Wong I, Rajapaksa S, Carney SA, Wormald PJ. Long term comparison between submucosal cauterization and powered reduction of the inferior turbinates. Laryngoscope. Sep 2006;116(9):1612-6. [Medline].

  27. Kizilkaya Z, Ceylan K, Emir H, Yavanaglu A, Unlu I, Samim E, et al. Comparison of radiofrequency tissue volume reduction and submucosal resection with microdebrider in inferior turbinate hypertrophy. Otolaryngol Head Neck Surg. Feb 2008;138(2):176-81. [Medline].

  28. Lawson W, Reino AJ. Correcting functional problems. Facial Plastic Surgery Clinics. 1994;2(4):501-520.

  29. Lee JY, Lee JD. Comparative study on the long-term effectiveness between coblation- and microdebrider-assisted partial turbinoplasty. Laryngoscope. May 2006;116(5):729-34. [Medline].

  30. Li KK, Powell NB, Riley RW, et al. Radiofrequency volumetric tissue reduction for treatment of turbinate hypertrophy: a pilot study. Otolaryngol Head Neck Surg. Dec 1998;119(6):569-73. [Medline].

  31. Mabry RL. Inferior turbinoplasty: patient selection, technique, and long-term consequences. Otolaryngol Head Neck Surg. Jan 1988;98(1):60-6. [Medline].

  32. Mabry RL. Surgery of the inferior turbinates: how much and when?. Otolaryngol Head Neck Surg. Oct 1984;92(5):571-6. [Medline].

  33. Martinez SA, Nissen AJ, Stock CR, Tesmer T. Nasal turbinate resection for relief of nasal obstruction. Laryngoscope. Jul 1983;93(7):871-5. [Medline].

  34. Meredith GM 2nd. Surgical reduction of hypertrophied inferior turbinates: a comparison of electrofulguration and partial resection. Plast Reconstr Surg. Jun 1988;81(6):891-9. [Medline].

  35. Moore GF, Freeman TJ, Ogren FP, Yonkers AJ. Extended follow-up of total inferior turbinate resection for relief of chronic nasal obstruction. Laryngoscope. Sep 1985;95(9 Pt 1):1095-9. [Medline].

  36. Nease CJ, Krempl GA. Radiofrequency treatment of turbinate hypertrophy: a randomized, blinded, placebo-controlled clinical trial. Otolaryngol Head Neck Surg. Mar 2004;130(3):291-9. [Medline].

  37. Ophir D, Shapira A, Marshak G. Total inferior turbinectomy for nasal airway obstruction. Arch Otolaryngol. Feb 1985;111(2):93-5. [Medline].

  38. Passali D, Lauriello M, Anselmi M, Bellussi L. Treatment of hypertrophy of the inferior turbinate: long-term results in 382 patients randomly assigned to therapy. Ann Otol Rhinol Laryngol. Jun 1999;108(6):569-75. [Medline].

  39. Passali D, Passali FM, Damiani V. Treatment of inferior turbinate hypertrophy: a randomized clinical trial. Ann Otol Rhinol Laryngol. Aug 2003;112(8):683-8. [Medline].

  40. Pollock RA, Rohrich RJ. Inferior turbinate surgery: an adjunct to successful treatment of nasal obstruction in 408 patients. Plast Reconstr Surg. Aug 1984;74(2):227-36. [Medline].

  41. Porter MW, Hales NW, Nease CJ, Krempl GA. Long-term results of inferior turbinate hypertrophy with radiofrequency treatment: a new standard of care?. Laryngoscope. 2006;116(4):554-7. [Medline].

  42. Rhee CS, Kim DY, Won TB, et al. Changes of nasal function after temperature-controlled radiofrequency tissue volume reduction for the turbinate. Laryngoscope. Jan 2001;111(1):153-8. [Medline].

  43. Utley DS, Goode RL, Hakim I. Radiofrequency energy tissue ablation for the treatment of nasal obstruction secondary to turbinate hypertrophy. Laryngoscope. May 1999;109(5):683-6. [Medline].

  44. Wexler D, Braverman I. Partial inferior turbinectomy using the microdebrider. J Otolaryngol. Jun 2005;34(3):189-93. [Medline].

  45. Williams HO, Fisher EW, Golding-Wood DG. 'Two-stage turbinectomy': sequestration of the inferior turbinate following submucosal diathermy. J Laryngol Otol. Jan 1991;105(1):14-6. [Medline].

  46. Younger RAL, Dento AB. Controversies in turbinate surgery. Facial Plastic Surgery Clinics. 1999;7(3):311-317.

Further Reading

Keywords

rhinoplasty, turbinate, turbinate reduction, nasal reduction, nasal surgery, turbinate surgery, intramural electrocautery, submucosal electrocautery, inferior turbinectomy, inferior turbinoplasty, partial inferior turbinectomy, submucosal turbinate resection

Contributor Information and Disclosures

Author

Elizabeth Whitaker, MD, Clinical Assistant Professor, Department of Otolaryngology, Division of Facial Plastic Surgery, Atlanta Surgical Group, PC
Elizabeth Whitaker, MD is a member of the following medical societies: American Academy of Facial Plastic and Reconstructive Surgery, American Academy of Otolaryngology-Head and Neck Surgery, American College of Surgeons, and American Medical Association
Disclosure: Nothing to disclose.

Medical Editor

Frederick J Menick, MD, Clinical Associate Professor, Department of Surgery, Division of Plastic Surgery, University of Arizona College of Medicine; Private Practice in Tucson, Arizona
Frederick J Menick, MD is a member of the following medical societies: American Association of Plastic Surgeons, American Society for Aesthetic Plastic Surgery, American Society of Plastic and Reconstructive Surgery, American Society of Plastic Surgeons, and Canadian Society of Plastic Surgeons
Disclosure: none None None

Pharmacy Editor

Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: Nothing to disclose.

Managing Editor

George Peck, Jr, MD, Consulting Staff, Department of Plastic Surgery, St Barnabas Hospital of New Jersey
George Peck, Jr, MD is a member of the following medical societies: American Society for Aesthetic Plastic Surgery
Disclosure: Nothing to disclose.

CME Editor

Nicolas (Nick) G Slenkovich, MD, Director, Colorado Plastic Surgery Center
Nicolas (Nick) G Slenkovich, MD is a member of the following medical societies: American Academy of Otolaryngology-Head and Neck Surgery, American College of Surgeons, American Medical Association, American Society of Aesthetic Plastic Surgery, American Society of Plastic Surgeons, and Colorado Medical Society
Disclosure: Nothing to disclose.

Chief Editor

Jorge I de la Torre, MD, FACS, Professor of Surgery and Physical Medicine and Rehabilitation, Residency Program Director, Division of Plastic Surgery, University of Alabama at Birmingham; Director, Center for Advanced Surgical Aesthetics
Jorge I de la Torre, MD, FACS is a member of the following medical societies: American Association of Plastic Surgeons, American Burn Association, American College of Surgeons, American Medical Association, American Society for Laser Medicine and Surgery, American Society for Reconstructive Microsurgery, American Society of Maxillofacial Surgeons, American Society of Plastic Surgeons, Association for Academic Surgery, and Medical Association of the State of Alabama
Disclosure: Nothing to disclose.

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.